propafenone has been researched along with ajmaline in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (40.91) | 18.7374 |
| 1990's | 7 (31.82) | 18.2507 |
| 2000's | 2 (9.09) | 29.6817 |
| 2010's | 4 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wunderlich, E | 1 |
| Heinemeyer, G; Köppel, C; Oberdisse, U | 1 |
| Somberg, J | 1 |
| Somberg, JC | 1 |
| Gmeiner, R; Sterz, H | 1 |
| Himmler, C; Klein, G; Neiss, A; Schlegl, J; Wirtzfeld, A | 1 |
| Bianchini, C; Meoli, P; Rovelli, F; Sanna, G | 1 |
| Bettini, R; Dal Forno, P; Disertori, M; Furlanello, F; Gramegna, L; Inama, G; Vergara, G | 1 |
| Bettini, R; Disertori, M; Durante, G; Furlanello, F; Guarnerio, M; Inama, G; Stirpe, E; Vergara, G | 1 |
| Bonatti, V; Botti, G; Disertori, M; Furlanello, F; Guarnerio, M; Inama, G; Rolli, A; Vergara, G | 1 |
| Bettini, R; Dal Forno, P; Disertori, M; Furlanello, F; Inama, G; Stefenelli, C; Vergara, G; Zuechi, S | 1 |
| Borggrefe, M; Breithardt, G; Chen, X; Haverkamp, W; Hief, C; Hindricks, G; Martinez-Rubio, A | 1 |
| Bachernegg, M; Decrinis, M; Domanowits, H; Kickenweiz, E; Laggner, AN; Stark, G; Stark, U; Sterz, F; Tritthart, HA | 1 |
| Lüderitz, B; Manz, M | 1 |
| Decrinis, M; Marx, D; Poppe, H; Schwarzl, I; Stark, G; Stark, U; Tritthart, HA; Weber, G | 1 |
| Decrinis, M; Schwarzl, I; Stark, G; Stark, U; Tritthart, HA | 1 |
| Dinckal, MH; Karaca, M | 1 |
| Calvelli, A; Chiatto, M; De Donato, V; De Rosa, F; Mancuso, P; Mazza, S; Spadafora, G | 1 |
| Akilli, A; Bilgin, M; Gul, I; Gungor, H; Yildiz, BS; Zoghi, M | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Cooper, J; Cui, Y; Fink, M; Gavaghan, DJ; Heath, BM; McMahon, NC; Mirams, GR; Noble, D; Sher, A | 1 |
| Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
4 review(s) available for propafenone and ajmaline
| Article | Year |
|---|---|
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil | 1985 |
[Progress in arrhythmology].
Topics: Adolescent; Adult; Aged; Ajmaline; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atropine; Cardiac Pacing, Artificial; Child; Electrocardiography; Exercise Test; Heart Conduction System; Humans; Middle Aged; Propafenone; Propiophenones; Sick Sinus Syndrome; Stimulation, Chemical; Verapamil; Wolff-Parkinson-White Syndrome | 1981 |
Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy.
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Disopyramide; Flecainide; Humans; Imidazoles; Pre-Excitation Syndromes; Propafenone; Quinidine; Sotalol; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Verapamil | 1993 |
[Ventricular preexcitation: is risk stratification feasible?].
Topics: Adolescent; Adult; Age Distribution; Ajmaline; Atrioventricular Node; Catheter Ablation; Child; Child, Preschool; Clinical Trials as Topic; Death, Sudden, Cardiac; Electrocardiography; Exercise Test; Feasibility Studies; Female; Heart Function Tests; Humans; Male; Middle Aged; Procainamide; Prognosis; Propafenone; Risk Assessment; Sex Distribution; Wolff-Parkinson-White Syndrome; Young Adult | 2010 |
4 trial(s) available for propafenone and ajmaline
| Article | Year |
|---|---|
[Efficacy of anti-arrhythmia agents].
Topics: Adult; Aged; Ajmaline; Androstanols; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Lidocaine; Male; Middle Aged; Placebos; Propafenone; Propiophenones | 1980 |
Antiarrhythmic effectiveness of propafenone compared to lorajmine in ventricular arrhythmias. Controlled clinical trial.
Topics: Adolescent; Adult; Aged; Ajmaline; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Monitoring, Physiologic; Propafenone; Propiophenones | 1983 |
Efficacy of ajmaline and propafenone in patients with accessory pathways: a prospective randomized study.
Topics: Accessory Nerve; Adolescent; Adult; Aged; Ajmaline; Atrial Fibrillation; Electrophysiology; Female; Heart; Heart Conduction System; Humans; Infusions, Intravenous; Male; Middle Aged; Propafenone; Prospective Studies; Refractory Period, Electrophysiological; Tachycardia, Atrioventricular Nodal Reentry; Wolff-Parkinson-White Syndrome | 1994 |
Action of ATP on ventricular automaticity.
Topics: Adenosine Triphosphate; Adrenergic beta-Antagonists; Ajmaline; Animals; Anti-Arrhythmia Agents; Austria; Cardiac Pacing, Artificial; Drug Interactions; Emergency Medical Services; Female; Guinea Pigs; Heart Ventricles; Humans; Injections, Intravenous; Male; Propafenone; Prospective Studies; Quinidine; Tachycardia, Supraventricular; Ventricular Function; Verapamil | 1994 |
14 other study(ies) available for propafenone and ajmaline
| Article | Year |
|---|---|
[Comment on the contribution by C. Hief, K. Frohner, A. Podczeck, W. Kaltenbrunner, M. Nürnberg and K. Steinbach: Value of a provocation test with diprafenone in patients with bifascicular block].
Topics: Ajmaline; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Heart Block; Humans; Propafenone | 1992 |
Clinical course and outcome in class IC antiarrhythmic overdose.
Topics: Ajmaline; Anti-Arrhythmia Agents; Bicarbonates; Bradycardia; Drug Overdose; Flecainide; Hemoperfusion; Humans; Hypertonic Solutions; Nausea; Prajmaline; Propafenone; Resuscitation; Retrospective Studies; Sodium; Sodium Bicarbonate; Tachycardia; Vomiting | 1990 |
New directions in antiarrhythmic drug therapy.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Death, Sudden; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tachycardia; Tocainide; Verapamil | 1984 |
[Conservative therapy of supraventricular tachycardias].
Topics: Adrenergic beta-Antagonists; Ajmaline; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Digitalis Glycosides; Electrocardiography; Humans; Propafenone; Propiophenones; Tachycardia; Verapamil | 1984 |
Worsening of arrhythmias during pharmacological treatment.
Topics: Adolescent; Adult; Aged; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Child; Disopyramide; Female; Follow-Up Studies; Humans; Lidocaine; Male; Middle Aged; Nadolol; Piperidines; Propafenone; Propanolamines; Propiophenones; Tocainide | 1984 |
[Sustained ventricular tachycardia: induced polymorphism. Clinical and electrophysiological aspects; therapeutic implications].
Topics: Adult; Aged; Ajmaline; Amiodarone; Electric Stimulation; Electrocardiography; Electrophysiology; Female; Heart Block; Heart Ventricles; Humans; Male; Middle Aged; Propafenone; Propiophenones; Tachycardia | 1984 |
[Validity and limits of invasive pharmacological tests in the treatment of malignant ventricular hyperkinetic arrhythmias].
Topics: Adult; Aged; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Evaluation; Female; Humans; Male; Mexiletine; Middle Aged; Propafenone; Propiophenones; Tachycardia | 1983 |
Rate-dependent effects of detajmium and propafenone on ventricular conduction and refractoriness in isolated guinea pig hearts.
Topics: Ajmaline; Animals; Anti-Arrhythmia Agents; Female; Guinea Pigs; Heart Conduction System; Heart Rate; Heart Ventricles; Male; Propafenone | 1996 |
Rate-dependent effects of ajmaline and propafenone on atrioventricular conduction.
Topics: Ajmaline; Animals; Anti-Arrhythmia Agents; Atrioventricular Node; Electrocardiography; Female; Guinea Pigs; Heart; Heart Conduction System; Male; Perfusion; Propafenone | 1996 |
Monomorphic and propafenone-induced polymorphic ventricular tachycardia in Brugada syndrome: a case report.
Topics: Adult; Ajmaline; Anti-Arrhythmia Agents; Brugada Syndrome; Bundle-Branch Block; Defibrillators, Implantable; Electrocardiography; Humans; Male; Propafenone; Tachycardia, Ventricular | 2006 |
Is a drug-challenge test with propafenone adequate to exclude Brugada syndrome?
Topics: Adrenergic beta-Antagonists; Adult; Ajmaline; Anti-Arrhythmia Agents; Brugada Syndrome; Defibrillators, Implantable; Electric Countershock; Electrocardiography; Female; Heart Conduction System; Humans; Predictive Value of Tests; Propafenone | 2013 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Computer Simulation; Dogs; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; HEK293 Cells; Humans; Ion Channels; Kinetics; Models, Cardiovascular; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Potassium Channel Blockers; Rabbits; Risk Assessment; Risk Factors; Sodium Channel Blockers; Sodium Channels; Torsades de Pointes; Transfection | 2011 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |